Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1991 1
1997 1
1999 1
2000 4
2001 1
2002 3
2003 5
2004 3
2005 13
2006 8
2007 8
2008 12
2009 8
2010 17
2011 18
2012 17
2013 17
2014 15
2015 20
2016 18
2017 12
2018 13
2019 17
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

205 results
Results by year

Citations

205 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis
Perner A, et al. N Engl J Med 2012 - Clinical Trial. PMID 22738085 Free article.
At 90 days after randomization, 201 of 398 patients (51%) assigned to HES 130/0.42 had died, as compared with 172 of 400 patients (43%) assigned to Ringer's acetate (relative risk, 1.17; 95% confidence interval [CI], 1.01 to 1.36; P=0.03); 1 patient in each group had end-stage kidney failure. In the 90-day period, 87 patients (22%) assigned to HES 130/0.42 were treated with renal-replacement therapy versus 65 patients (16%) assigned to Ringer's acetate (relative risk, 1.35; 95% CI, 1.01 to 1.80; P=0.04), and 38 patients (10%) and 25 patients (6%), respectively, had severe bleeding (relative risk, 1.52; 95% CI, 0.94 to 2.48; P=0.09). ...
At 90 days after randomization, 201 of 398 patients (51%) assigned to HES 130/0.42 had died, as compared with 172 of 400 patients (43%) assi …
Re: Fra ketobemidon til oksykodon
Dale O, et al. Tidsskr Nor Laegeforen 2017. Among authors: Klepstad P. PMID 28332785 Norwegian. Free article.
Re: Fra ketobemidon til morfin eller oksykodon
Dale O, et al. Tidsskr Nor Laegeforen 2016. Among authors: Klepstad P. PMID 28004537 Norwegian. Free article.
Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study
Azoulay E, et al. Intensive Care Med 2017 - Clinical Trial. PMID 28948369
After propensity score matching, HFNC, but not NIV, had an effect on IMV rate (HR = 0.77, 95% CI 0.59-1.00, p = 0.05). ICU, hospital, and day-90 mortality rates were 32.4, 44.1, and 56.4%, respectively. ...
After propensity score matching, HFNC, but not NIV, had an effect on IMV rate (HR = 0.77, 95% CI 0.59-1.00, p = 0.05). ICU, hospital, …
Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy
Bauer PR, et al. Eur Respir J 2019. Among authors: Klepstad P. PMID 31109985
Bronchoscopy was associated with higher ICU (40% versus 28%; p<0.0001) and hospital mortality (49% versus 41%; p=0.003). The overall rate of undiagnosed causes was 13%. ...
Bronchoscopy was associated with higher ICU (40% versus 28%; p<0.0001) and hospital mortality (49% versus 41%; p=0.003). Th …
Influenza and associated co-infections in critically ill immunosuppressed patients
Martin-Loeches I, et al. Crit Care 2019. Among authors: Klepstad P. PMID 31046842 Free PMC article.
On crude analysis, influenza infection status was associated with ICU mortality (P < 0.001) but not hospital mortality (P = 0.09). ...A propensity score-matched analysis did not show a difference in hospital mortality attributable to influenza infection (OR = 1.01, 95%CI 0.90-1.13, P = 0.85). ...
On crude analysis, influenza infection status was associated with ICU mortality (P < 0.001) but not hospital mortality (P = …
205 results
Jump to page
Feedback